Rhenman & Partners Asset Management Ab Macrogenics Inc Transaction History

Rhenman & Partners Asset Management Ab

$1.01 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $645,932 - $2.87 Million	-287,081 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.12 - $16.9 $110,204 - $229,366	-13,572 Reduced 4.51%	287,081 $2.53 Million
Q4 2021 Feb 11, 2022	SELL	$15.91 - $21.88 $3.89 Million - $5.35 Million	-244,507 Reduced 44.85%	300,653 $4.9 Million
Q1 2021 May 14, 2021	SELL	$18.99 - $33.2 $1.52 Million - $2.65 Million	-79,840 Reduced 12.77%	545,160 $17.4 Million
Q4 2020 Jan 19, 2021	SELL	$19.41 - $26.0 $207,900 - $278,486	-10,711 Reduced 1.68%	625,000 $14.3 Million
Q3 2020 Oct 13, 2020	SELL	$24.69 - $31.6 $970,045 - $1.24 Million	-39,289 Reduced 5.82%	635,711 $16 Million
Q2 2020 Jul 16, 2020	SELL	$5.2 - $29.12 $1.69 Million - $9.46 Million	-325,000 Reduced 32.5%	675,000 $18.8 Million
Q1 2020 Apr 16, 2020	SELL	$4.28 - $12.11 $256,800 - $726,600	-60,000 Reduced 5.66%	1,000,000 $5.82 Million
Q4 2019 Jan 17, 2020	BUY	$7.95 - $12.27 $2.07 Million - $3.2 Million	260,627 Added 32.6%	1,060,000 $11.5 Million
Q3 2019 Oct 16, 2019	SELL	$12.44 - $17.48 $718,982 - $1.01 Million	-57,796 Reduced 6.74%	799,373 $10.2 Million
Q2 2019 Jul 22, 2019	SELL	$14.51 - $19.71 $1.6 Million - $2.17 Million	-110,017 Reduced 11.37%	857,169 $14.5 Million
Q1 2019 Apr 11, 2019	BUY	$11.11 - $25.6 $4.72 Million - $10.9 Million	425,000 Added 78.39%	967,186 $17.4 Million
Q4 2018 Feb 05, 2019	BUY	$11.75 - $21.42 $2.36 Million - $4.3 Million	200,600 Added 58.73%	542,186 $6.89 Million
Q3 2018 Oct 03, 2018	BUY	$19.26 - $23.46 $319,446 - $389,107	16,586 Added 5.1%	341,586 $7.32 Million
Q2 2018 Jul 20, 2018	BUY	$19.78 - $24.67 $494,500 - $616,750	25,000 Added 8.33%	325,000 $6.71 Million
Q1 2018 Apr 11, 2018	SELL	$18.89 - $32.46 $162,529 - $279,285	-8,604 Reduced 2.79%	300,000 $7.55 Million
Q4 2017 Jan 19, 2018	BUY	$16.19 - $20.3 $1.4 Million - $1.76 Million	86,690 Added 39.06%	308,604 $5.86 Million
Q3 2017 Oct 13, 2017	BUY	$15.52 - $18.94 $3.44 Million - $4.2 Million	221,914	221,914 $4.1 Million

Others Institutions Holding MGNX

# of Institutions

150

Shares Held

60.3M

Call Options Held

218K

Put Options Held

259K

Bellevue Group Ag Kuesnacht, V8

9.94M
Shares

$36.4 Million
0.71% of portfolio
Armistice Capital, LLC New York, NY

6M
Shares

$22 Million
0.33% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$19.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.14M
Shares

$15.1 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.31M
Shares

$12.1 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $225M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account